999
Participants
Start Date
October 4, 2022
Primary Completion Date
May 31, 2028
Study Completion Date
May 31, 2028
Relugolix
Relugolix 120-mg tablet administered orally once daily following an oral loading dose of 360 mg (3 x 120-mg tablets) on Day 1
Mount Sinai Hospital, New York
Optum Medical Care, P. C., Mount Kisco
Crystal Run Healthcare, Middletown
SUNY Upstate Medical Institution, Syracuse
Mohawk Valley Health Services, Utica
GU, Inc., Latrobe
Keystone Urology Specialist, Lancaster
Spokenword Clinical Trials, Easton
Urologic Surgeons of Washington, Washington D.C.
MemorialCare, Long Beach Memorial Medical Center, Washington D.C.
John Hopkins, Baltimore
Maryland Oncology Hematology, Columbia
Medstar Georgetown University Hospital, Columbia
Chesapeake Urology Associates, Baltimore
Potomac Urology Center, PC, Alexandria
MedAtlantic, Richmond
Urology of Virginia, PLLC, Virginia Beach
Associated Urologist of North Carolina, Raleigh
Durham VA Healthcare, Durham
GenesisCare USA, Greenville
DJL Clinical Research, PLLC, Charlotte
Lowcountry Urology Clinics, North Charleston
Carolina Urologic Research Center, LLC, Myrtle Beach
Georgia Urology, Decatur
Emory University, Atlanta
Advanced Urology Institute, Daytona Beach
Memorial Healthcare System, Hollywood
United Medical Group, Miami
SG Research LLC, Miami
Florida Urology Partners, LLP, Tampa
Bay Pines VA Healthcare System, Bay Pines
Genesis Care USA, Naples
Manatee Medical Research Institute, LLC, Bradenton
Urology Centers of Alabama, Homewood
Urology Associates of Mobile, Mobile
University of Tennessee Medical Center, Knoxville
The Conrad Pearson Clinic, Germantown
Baptists Health Lexington, Lexington
Central Ohio Urology Group, Gahanna
The University of Toledo, Toledo
University Hospitals, Cleveland
NEO Urology Associates, Inc., Boardman
University of Cincinnati Medical Center, Cincinnati
Clinical Inquest Center Ltd, Beavercreek
Premier Clinical Research LLC dba STAT Research, Springboro
Urology of Indiana, Carmel
Urologic Specialists of Northwest Indiana, Merrillville
Michigan Institute of Urology, Troy
GenesisCare USA, Troy
Greater Regional Health, Creston
Aspirus, Wausau
Wisconsin Institute of Urology, Neenah
Minnesota Urology, Woodbury
PRiSMS Group LLC, Arlington Heights
Comprehensive Urologic Care, Lake Barrington
UroPartners Research, Glenview
Northwestern University, Evanston
Associated Urological Specialists, Chicago Ridge
Advanced Urology Associates, New Lenox
Duly Health and Care, Lisle
Specialty Clinical Research of St. Louis, St Louis
University of Kansas Medical Center, Kansas City
Wichita Urology Group, P.A., Wichita
Southern Urology, Lafayette
Arkansas Urology Research Center, Little Rock
Hmu, Crc Llc, Houston
MD Anderson, Houston
New Horizon Medical Group, LLC, Houston
Ascend Pharma Holdings, Houston
Urology San Antonio, P.A. dba USA Clinical Trials, San Antonio
The Urology Place, San Antonio
Urology Austin, Austin
Rocky Mountain Regional VA Medical Center, Aurora
Urology Associates, Lone Tree
The Urology Center of Colorado, Denver
Colorado Urology, Lakewood
Banner MD Anderson Cancer Center, Greeley
Dignity Health, Phoenix
Arizona Urology Specialists, PLLC, Tucson
USC Norris Cancer Center, Los Angeles
Tower Urology, Los Angeles
VA Greater Los Angeles Medical Center, Los Angeles
City of Hope, Duarte
UCSD, La Jolla
Genesis Research LLC, San Diego
Tri Valley Urology, Murrieta
Urology Associates of Central California, Fresno
Associated Medical Professionals of NY, PLLC, Syracuse
Golden State Urology, Stockton
Oregon Urology Institute, Springfield
Spokane Urology, P.S., Spokane
The Stamford Hospital, Stamford
"Summit Medical Group, P.A. , New Jersey Urology"
AtlanticCare Cancer Institute, Egg Harbor
The Valley Hospital, Paramus
Regional Cancer Care Associates, Teaneck
Sumitomo Pharma America, Inc.
INDUSTRY